Skip to main content
Funding round pulls in $28.5M for Comet

A round of Series A funding pulled in $28.5 million for Comet Therapeutics, which intends to use the proceeds to fund the development of precursors of coenzyme A for the treatment of immune, metabolic and neurological disorders that have dysregulated metabolism of coenzyme A.

Full Story: